Life Science Platform Harnesses Power of Online Communities to Promote
True Scientific Collaboration
COLUMBIA, S.C. & COLOGNE, GERMANY, October 9 /CNW/ - Collexis (OTCBB:
CLXS), a leading developer of high-definition search and discovery software,
and their German partner, SyynX Solutions, today announced they will preview a
new life sciences social networking site to representatives from global book
publishing and multimedia companies at the Frankfurt Book Fair in Frankfurt,
Germany, from Wednesday, October 10, 2007 to Friday, October 12, 2007. This
online community represents the next generation in social networks. The
comprehensive system of pre-populated expert profiles, coupled with the
ability to analyze all associated professional connections within the network,
allows scientists and researchers across multiple organizations to share data
and collaborate in ways never before considered.
Over the next few weeks, a controlled group of research thought leaders
are testing the site for a public launch slated for January, when the site's
name and web address will be formally released to the public. However,
Frankfurt Book Fair attendees can gain access to the site at the companies'
joint booth, number 417 in Hall 4.2, at any time during the conference, or
during a wine and cheese reception on Thursday, October 9, from 4 p.m. to 6
Designed to promote collaborative research and development in advancing
medical science, the site is the first social networking application to
incorporate pre-generated expert profiles of over 1.4 million biomedical
experts from more than 150 countries. It currently houses approximately 12
million pre-established network connections, automatically generated from over
six million scientific publications from 6,500 journals. Contrary to the first
generation social networks like Facebook and LinkedIn, this life science open
platform goes to the next level and reflects the real-life activity network of
the experts worldwide.
"Social networking isn't just for teenagers. There are a growing number
of academics who are finding that online communities are the perfect way to
share, collaborate and discuss their work," said Bill Kirkland, Collexis CEO.
"But until now, an efficient way to coordinate the abundance of available
digital information did not exist. The technology behind our site now makes it
possible for researchers to collaborate in a way not previously possible."
"When a researcher logs into the site, available at no-charge, they will
immediately see a robust synopsis of their publications, interests and
network," added Kirkland. "The depth of this information, encompassing almost
every published researcher in the biomedical sciences field worldwide, is what
makes the site incredibly powerful. It also serves as a definitive source to
identify relationships to others within the community, either by topic or
The social networking site is based on Collexis' proprietary Fingerprint
technology, a valuable research tool already employed by organizations such
as: Johns Hopkins, The Mayo Clinic, Harvard University and The National
Institute of Health.
"Taking the Collexis technology, which has become the platform of choice
for leading biomedical companies, and combining it with a free social network
application was really the next logical step," said Christian Herzog, MD, CEO
of SyynX Solutions. "Thanks to the genius of Martin Schmidt, our chief
technology officer, in collaboration with the Collexis leadership, the
research community will now be able to instantaneously identify relevant
expertise in a specific research area and start collaborating directly. Plus,
we see the next generations of this platform expanding beyond biomedical
research and into larger, global R&D development efforts."
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of High Definition Search
and Discovery software since 1999, is headquartered in Columbia, South
Carolina (USA) with two subsidiaries; Collexis Inc. in Columbia, South
Carolina, USA and Collexis, B.V. in Geldermalsen, The Netherlands. Collexis
proprietary technology builds conceptual profiles of text, called
Fingerprints, from documents, websites, e-mails and other digitized content
and matches them with a comprehensive list of pre-defined "fingerprinted"
concepts to make research results more relevant and efficient. This matching
of concepts eliminates the ambiguity and lack of priority associated with word
searches. The results are often described as "finding needles in many
haystacks." Through this novel approach, Collexis can build unique
applications to search, index and aggregate information as well as prioritize,
trend and predict data based on sources in multiple industries without the
limitations of language or dialect. Collexis shares of common stock are traded
under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more
information, please visit www.collexis.com.
About SyynX Solutions GmbH
SyynX Solutions GmbH
SyynX Solutions GmbH is a German software company which focuses on text
mining based applications for the areas of life science and health care.
Collexis and SyynX are already co-operating closely since almost ten years on
the technical and commercial level. The SyynX applications based on the
Collexis fingerprint technology are used by customers like universities,
pharmaceutical and biotech companies around the world. The text mining
applications like the SyynX Knowledge Dashboard helps the user to analyze
large text corpora without applying standard search approaches and provides
him automatically with expert profiles, trends and knowledge discovery
routines. For more information please visit www.syynx.de.
This press release contains forward-looking statements. Such statements
are valid only as of today, and we disclaim any obligation to update this
information. These statements are subject to known and unknown risks and
uncertainties that may cause actual future experience and results to differ
materially from the statements made. These statements are based on our current
beliefs and expectations as to future outcomes. Factors that could affect
future performance include business and economic trends, the ability to
continue funding operating losses, fluctuations in operating results,
continued success in developing our research software and other risk factors
as disclosed in our public filings with the Securities and Exchange
For further information:
For further information: Media: Avalanche Strategic Comm. Denyse
Dabrowski, +1-201-488-0049 email@example.com or Collexis On-Site:
Collexis, Inc. Darrell W. Gunter, +1-803-7271113 firstname.lastname@example.org or SyynX
Solutions GmbH: Christian Herzog, +49-221-16252050 email@example.com